@entity370 and XXXX : a comparative study.

@entity1 @entity706 @entity784 @entity1072 @entity1892 @entity6444 @entity1893 @entity370 @entity204 @entity978
AIM: To assess the clinical features and outcome of @entity706 when associated with @entity370 and to determine whether this association gives @entity706 a better prognosis. DESIGN: Multicentre retrospective cohort study. METHODS: Retrospective chart review. RESULTS: Twenty-one @entity1 were included (9 males, 12 females). Median age at @entity370 diagnosis was 48 years (range: 24-68 years). In 14 cases, @entity706 occurred within a previously known @entity370 . Five @entity1 received a concomitant diagnosis of @entity370 and @entity706 , whereas @entity706 preceded @entity370 in two @entity1 . Three @entity1 were diagnosed with @entity978 and 18 @entity1 with @entity1893 ( @entity1892 ( @entity1892 ) (n = 11), @entity706 (n = 2), @entity1072 /small @entity1072 (n = 2), anaplastic large cell @entity706 ALK + (n = 1), angioimmunoblastic @entity784 (n = 1) and @entity6444 (n = 1)). Thirteen @entity1 were alive and in complete remission. Median age at the time of diagnosis of @entity370 was lower in @entity1 with @entity706 compared with @entity1 with @entity370 preceding @entity706 (34 years vs. 51 years, P = 0.01). @entity1 presenting with @entity1892 associated with @entity370 were compared with @entity1892 without @entity370 . No statistical difference was found in the risk of @entity204 or progression between the two groups (P = 0.685). CONCLUSIONS: We report here the largest series of @entity706 associated @entity370 @entity1 . As opposed to previous studies, we observed a predominance of @entity1 with @entity1892 . Our study confirms the concept of the @entity706 . Large @entity1892 does not have a better prognosis when associated with @entity370 .
